Cogent Biosciences, Inc. - COGT
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 03, 2026 | — | A | A | 686.0 | 0.0 | 0.0 | 686.0 | View | |
| Mar 31, 2026 | — | C | D | 28,000.0 | 0.0 | 0.0 | 39,414.0 | View | |
| Mar 31, 2026 | — | S | D | 7,000,000.0 | 34.66 | 242,620,000.0 | 5,503,418.0 | View | |
| Mar 31, 2026 | — | C | A | 7,000,000.0 | — | — | 12,503,418.0 | View | |
| Jan 22, 2026 | — | S | D | 3,500,000.0 | 36.4 | 127,400,000.0 | 5,503,418.0 | View | |
| Jan 05, 2026 | — | A | A | 643.0 | 0.0 | 0.0 | 643.0 | View | |
| Dec 30, 2025 | Chief Medical Officer | S | D | 82,642.0 | 38.7 | 3,198,245.4 | 133,938.0 | View | |
| Dec 30, 2025 | Chief Financial Officer | S | D | 77,000.0 | 38.68 | 2,978,360.0 | 131,834.0 | View | |
| Dec 30, 2025 | Chief Legal Officer | S | D | 65,000.0 | 38.7 | 2,515,500.0 | 109,398.0 | View | |
| Dec 30, 2025 | Chief Scientific Officer | S | D | 90,000.0 | 38.74 | 3,486,600.0 | 140,002.0 | View | |
| Dec 19, 2025 | Chief Financial Officer | A | A | 65,000.0 | 0.0 | 0.0 | 65,000.0 | View | |
| Dec 19, 2025 | Chief Financial Officer | F | D | 145,007.0 | 39.45 | 5,720,526.15 | 208,834.0 | View | |
| Dec 19, 2025 | Chief Financial Officer | A | A | 300,000.0 | 0.0 | 0.0 | 353,841.0 | View | |
| Dec 19, 2025 | Chief Financial Officer | A | A | 50,000.0 | 0.0 | 0.0 | 53,841.0 | View | |
| Dec 19, 2025 | Chief Medical Officer | A | A | 65,000.0 | 0.0 | 0.0 | 65,000.0 | View | |
| Dec 19, 2025 | Chief Medical Officer | F | D | 154,716.0 | 39.45 | 6,103,546.2 | 216,580.0 | View | |
| Dec 19, 2025 | Chief Medical Officer | A | A | 320,000.0 | 0.0 | 0.0 | 371,296.0 | View | |
| Dec 19, 2025 | Chief Medical Officer | A | A | 50,000.0 | 0.0 | 0.0 | 51,296.0 | View | |
| Dec 19, 2025 | Chief Legal Officer | A | A | 55,000.0 | 0.0 | 0.0 | 55,000.0 | View | |
| Dec 19, 2025 | Chief Legal Officer | F | D | 125,602.0 | 39.45 | 4,954,998.9 | 174,398.0 | View | |
| Dec 19, 2025 | Chief Legal Officer | A | A | 260,000.0 | 0.0 | 0.0 | 300,000.0 | View | |
| Dec 19, 2025 | Chief Legal Officer | A | A | 40,000.0 | 0.0 | 0.0 | 40,000.0 | View | |
| Dec 19, 2025 | Chief Commercial Officer | A | A | 65,000.0 | 0.0 | 0.0 | 65,000.0 | View | |
| Dec 19, 2025 | Chief Commercial Officer | F | D | 94,800.0 | 39.45 | 3,739,860.0 | 216,650.0 | View | |
| Dec 19, 2025 | Chief Commercial Officer | A | A | 214,000.0 | 0.0 | 0.0 | 311,450.0 | View | |
| Dec 19, 2025 | Chief Commercial Officer | A | A | 50,000.0 | 0.0 | 0.0 | 97,450.0 | View | |
| Dec 19, 2025 | President and CEO | A | A | 245,000.0 | 0.0 | 0.0 | 245,000.0 | View | |
| Dec 19, 2025 | President and CEO | F | D | 367,497.0 | 39.45 | 14,497,756.65 | 657,503.0 | View | |
| Dec 19, 2025 | President and CEO | A | A | 840,000.0 | 0.0 | 0.0 | 1,025,000.0 | View | |
| Dec 19, 2025 | President and CEO | A | A | 185,000.0 | 0.0 | 0.0 | 185,000.0 | View | |
| Dec 19, 2025 | Chief Scientific Officer | A | A | 65,000.0 | 0.0 | 0.0 | 65,000.0 | View | |
| Dec 19, 2025 | Chief Scientific Officer | F | D | 139,998.0 | 39.45 | 5,522,921.1 | 230,002.0 | View | |
| Dec 19, 2025 | Chief Scientific Officer | A | A | 320,000.0 | 0.0 | 0.0 | 370,000.0 | View | |
| Dec 19, 2025 | Chief Scientific Officer | A | A | 50,000.0 | 0.0 | 0.0 | 50,000.0 | View |